These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38689006)

  • 21. Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease.
    Sampedro F; Pérez-González R; Martínez-Horta S; Marín-Lahoz J; Pagonabarraga J; Kulisevsky J
    Parkinsonism Relat Disord; 2020 May; 74():43-49. PubMed ID: 32334380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical Macro- and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder.
    Pardo J; Montal V; Campabadal A; Oltra J; Uribe C; Roura I; Bargalló N; Martí MJ; Compta Y; Iranzo A; Fortea J; Junqué C; Segura B
    Mov Disord; 2024 May; 39(5):814-824. PubMed ID: 38456361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. More than an "inverted-U"? An exploratory study of the association between the catechol-o-methyltransferase gene polymorphism and executive functions in Parkinson's disease.
    Fang YJ; Tan CH; Tu SC; Liu CY; Yu RL
    PLoS One; 2019; 14(3):e0214146. PubMed ID: 30897147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
    Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
    Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson's disease: A 4-year follow-up.
    Garcia-Diaz AI; Segura B; Baggio HC; Uribe C; Campabadal A; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2018 Jan; 46():62-68. PubMed ID: 29132765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-up.
    Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2019 Jul; 64():286-292. PubMed ID: 31103485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catechol-O-methyltransferase gene (COMT) is associated with neurocognitive functioning in patients with sickle cell disease.
    Heitzer AM; Rashkin SR; Trpchevska A; Longoria JN; Rampersaud E; Olufadi Y; Wang WC; Raches D; Potter B; Steinberg MH; King AA; Kang G; Takemoto CM; Hankins JS
    Curr Res Transl Med; 2024 Jun; 72(2):103433. PubMed ID: 38244277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catechol-o-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls.
    Raznahan A; Greenstein D; Lee Y; Long R; Clasen L; Gochman P; Addington A; Giedd JN; Rapoport JL; Gogtay N
    Neuroimage; 2011 Aug; 57(4):1517-23. PubMed ID: 21620981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catechol-O-methyltransferase (COMT) genetic variants are associated with cognitive decline in patients with Parkinson's disease.
    Lin CH; Fan JY; Lin HI; Chang CW; Wu YR
    Parkinsonism Relat Disord; 2018 May; 50():48-53. PubMed ID: 29439855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between function and structure of the triple network and catechol-O-methyltransferase val
    Kang Y; Huang K; Cai S; Wang H; Liu J; Wang Y; Lv Y; Zhang W; Wang Q; Huang L; Wang J; Tian J
    Neurosci Lett; 2018 Nov; 687():65-70. PubMed ID: 30240822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
    Gasca-Salas C; García-Lorenzo D; Garcia-Garcia D; Clavero P; Obeso JA; Lehericy S; Rodríguez-Oroz MC
    Brain Imaging Behav; 2019 Feb; 13(1):180-188. PubMed ID: 28710667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population.
    Torkaman-Boutorabi A; Ali Shahidi G; Choopani S; Reza Zarrindast M
    Folia Neuropathol; 2012; 50(4):382-9. PubMed ID: 23319194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortical thinning across Parkinson's disease stages and clinical correlates.
    Wilson H; Niccolini F; Pellicano C; Politis M
    J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of gender and genetics on emotion processing in Parkinson's disease - A multimodal study.
    Heller J; Mirzazade S; Romanzetti S; Habel U; Derntl B; Freitag NM; Schulz JB; Dogan I; Reetz K
    Neuroimage Clin; 2018; 18():305-314. PubMed ID: 29876251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.
    Hao H; Shao M; An J; Chen C; Feng X; Xie S; Gu Z; Chan P;
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1041-5. PubMed ID: 25034874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced gray matter volume in cognitively preserved COMT
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Brain Imaging Behav; 2020 Apr; 14(2):321-328. PubMed ID: 30612340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
    Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
    J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
    Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Catechol-O-Methyltransferase Gene rs4680 Polymorphism and Levodopa Induced Dyskinesia in Parkinson's Disease: A Meta-Analysis and Systematic Review.
    Dwivedi A; Dwivedi N; Kumar A; Singh VK; Pathak A; Chaurasia RN; Mishra VN; Mohanty S; Joshi D
    J Geriatr Psychiatry Neurol; 2023 Mar; 36(2):98-106. PubMed ID: 35603896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catechol-O-methyltransferase Val158Met polymorphism: modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease.
    Wu H; Dong F; Wang Y; Xiao Q; Yang Q; Zhao J; Quinn TJ; Chen SD; Liu J
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1094-6. PubMed ID: 25108642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.